Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab

BACKGROUND: Although a recent randomized clinical trial has demonstrated that the objective response rate to nivolumab for metastatic gastric cancer was 11.2%, there was no patients confirmed complete response. Herein, we report on a case of liver metastasis arising from early gastric cancer in whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Namikawa, Tsutomu, Ishida, Nobuko, Tsuda, Sachi, Fujisawa, Kazune, Munekage, Eri, Iwabu, Jun, Munekage, Masaya, Uemura, Sunao, Tsujii, Shigehiro, Maeda, Hiromichi, Kitagawa, Hiroyuki, Kobayashi, Michiya, Hanazaki, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033840/
https://www.ncbi.nlm.nih.gov/pubmed/29978335
http://dx.doi.org/10.1186/s40792-018-0479-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033840/
https://www.ncbi.nlm.nih.gov/pubmed/29978335
http://dx.doi.org/10.1186/s40792-018-0479-3

Ejemplares similares